Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-47571

Single-particle
3.15 Å
EMD-47571
3D View Gallery
Deposition: 30/10/2024
Map released: 20/11/2024
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-47571
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9e6k summary report (pdf.gz) Map and 9e6k FULL report (pdf.gz)
EMICSS annotations (xml)

Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cells.

EMD-47571

Single-particle
3.15 Å
EMD-47571
3D View Gallery
Deposition: 30/10/2024
Map released: 20/11/2024
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Deposited maps
Colour Filename Category Contour level View
Author Estimated*
emd_47571.map.gz Primary map 0.08 Apply
emd_47571_half_map_2.map.gz Half map -
emd_47571_half_map_1.map.gz Half map -
Fitted models
PDB ID Representation Colour mode View
ALL
9e6k

Please note: maps may be downsampled for visualisation, to view the original resolution map please download the map and drag and drop into the mol* online viewer.